Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. Brevard
    4. ›
  4. Melbourne
    5. ›
  5. INSPIRED THERAPEUTICS LLC

INSPIRED THERAPEUTICS LLC - Florida Company Profile

Company claim

Is this your business?

Get access!

Company Details

Entity Name: INSPIRED THERAPEUTICS LLC
Jurisdiction: FLORIDA
Filing Type: Foreign Limited Liability Co.
Status: Inactive

The business entity is inactive. This status may signal operational issues or voluntary closure, raising concerns about the business's ability to repay loans and requiring careful risk assessment by lenders.

Date Filed: 19 May 2017 (8 years ago)
Date of dissolution: 27 Sep 2024 (10 months ago)
Last Event: REVOKED FOR ANNUAL REPORT
Event Date Filed: 27 Sep 2024 (10 months ago)
Document Number: M17000004328
FEI/EIN Number 821361471

Federal Employer Identification (FEI) Number assigned by the IRS.
Address: 6736 ARROYO DRIVE, MELBOURNE, FL, 32940, US
Mail Address: 6736 Arroyo Drive, Melbourne, FL, 32940, US
ZIP code: 32940
City: Melbourne
County: Brevard
Place of Formation: DELAWARE

Key Officers & Management

Name Role Address
DASSE KURT APH.D. Manager 15 N. INDIAN RIVER DRIVE, COCOA, FL, 329224728
WHITING JOHN KIV Manager 150 DORCHESTER AVE, SOUTH BOSTON, MA, 02127
GELLMAN BARRY N Manager 6736 ARROYO DRIVE, MELBOURNE, FL, 32940
PETIT PRISCILLA PH.D. Manager 10804 Goldfish Circle, ORLANDO, FL, 32825
GELLMAN Barry Agent 6736 ARROYO DRIVE, MELBOURNE, FL, 32940

Events

Event Type Filed Date Value Description
REVOKED FOR ANNUAL REPORT 2024-09-27 - -
CHANGE OF MAILING ADDRESS 2023-04-19 6736 ARROYO DRIVE, MELBOURNE, FL 32940 -
REGISTERED AGENT NAME CHANGED 2023-04-19 GELLMAN, Barry -
REGISTERED AGENT ADDRESS CHANGED 2023-04-19 6736 ARROYO DRIVE, MELBOURNE, FL 32940 -
LC AMENDMENT 2022-09-28 - -
CHANGE OF PRINCIPAL ADDRESS 2022-09-28 6736 ARROYO DRIVE, MELBOURNE, FL 32940 -

Debts

Document Number Status Case Number Name of Court Date of Entry Expiration Date Amount Due Plaintiff
J25000066949 ACTIVE 1000001028342 BREVARD 2025-01-23 2045-01-29 $ 24,974.60 STATE OF FLORIDA, DEPARTMENT OF REVENUE, MELBOURNE SERVICE CENTER, 100 RIALTO PL STE 800, MELBOURNE FL329013004

Documents

Name Date
ANNUAL REPORT 2023-04-19
LC Amendment 2022-09-28
ANNUAL REPORT 2022-03-27
ANNUAL REPORT 2021-03-15
ANNUAL REPORT 2020-01-20
ANNUAL REPORT 2019-05-16
ANNUAL REPORT 2018-04-20
Foreign Limited 2017-05-19

USAspending Awards / Financial Assistance

Date:
2022-09-24
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DEVELOPMENT OF THE INSPIRED THERAPEUTICS NEOMATE MECHANICAL CIRCULATORY SUPPORT SYSTEM FOR NEONATES AND INFANTS - PROJECT SUMMARY/ABSTRACT UP TO 14,000 CHILDREN IN THE US ARE HOSPITALIZED WITH HEART FAILURE (HF)-RELATED CONDITIONS EACH YEAR WITH A MORTALITY RATE OF 7-15%. HEART TRANSPLANT IS THE GOLD STANDARD OF THERAPY, BUT THE MORTALITY RATE WHILE ON THE WAITING LIST IS 5-39%; THUS, USE OF MECHANICAL CIRCULATORY SUPPORT (MCS) DEVICES PLAYS AN IMPORTANT ROLE IN SUPPORTING CARDIOVASCULAR FUNCTION IN THIS CHALLENGING AND HETEROGENOUS PATIENT POPULATION. MCS OPTIONS FOR NEONATES AND INFANTS <10KG ARE ESPECIALLY LIMITED, AS THEIR BODY HABITUS RENDERS THEM TOO SMALL TO RECEIVE IMPLANTABLE TECHNOLOGY. THE OBJECTIVE OF THIS PROJECT IS TO COMPLETE DEVELOPMENT OF THE INSPIRED THERAPEUTICS NEOMATE SYSTEM DESIGNED TO PROVIDE UP TO 30 DAYS OF MCS AS AN EXTRACORPOREAL LEFT VENTRICULAR ASSIST DEVICE (LVAD) FOR NEONATE AND INFANT HF PATIENTS. THE NEOMATE SYSTEM IS COMPRISED OF A COMPACT, MINIATURE CENTRIFUGAL ROTARY PUMP, UNIVERSAL DRIVER (CONTROLLER WITH AN EMBEDDED MAGNETICALLY LEVITATED (MAGLEV) MOTOR), AND PERIPHERAL COMPONENTS (SMART BATTERY, TOUCH-SCREEN MONITOR). BUILDING UPON THE SUCCESSFUL DEVELOPMENT OF THE PROTOTYPE AND FEASIBILITY TESTING (COMPLETED IN SBIR PHASE I), THE NEXT TWO DESIGN ITERATIONS WILL BE COMPLETED IN THIS SBIR PHASE II, INCLUDING COMPUTATIONAL FLUID DYNAMICS (CFD) ANALYSES TO PREDICT FLOW DYNAMICS AND HEMOLYSIS RISK (AIM 1), DEVELOPMENT OF THE NEOMATE PUMP (AIM 1), AND DEVELOPMENT OF THE NEOMATE INTEGRATED CONTROLLER AND MOTOR WITH PERIPHERALS (AIM 2). THE NEOMATE SYSTEM (2ND AND 3RD DESIGN) ITERATIONS WILL BE TESTED IN STATIC AND DYNAMIC MOCK FLOW LOOPS AND ACUTE AND CHRONIC OVINE MODELS TO EVALUATE HYDRODYNAMIC, HEMODYNAMIC, AND HEMOCOMPATIBILITY PERFORMANCE (AIM 3). DATA WILL BE USED TO REFINE THE CFD MODELS AND TO ITERATIVELY IMPROVE THE ENGINEERING DESIGN, FABRICATION, AND PERFORMANCE OF THE NEOMATE SYSTEM. POTENTIAL ADVANTAGES OF THE NEOMATE SYSTEM INCLUDE: (1) DISPOSABLE LOW-COST PUMPS FOR SHORT-TERM MCS SUPPORT; (2) REUSABLE MAGLEV UNIVERSAL CONTROLLER WITH INTEGRATED MOTOR; (3) THE PLATFORM TECHNOLOGY MAY SUPPORT MULTIPLE FUTURE CLINICAL CARDIOPULMONARY INDICATIONS FOR USE; (4) SMALLEST DIAMETER IMPELLER (27MM) AND COMPACT, INTEGRATED, AND MINIATURE CONTROLLER (51MM DIAMETER, 115MM HEIGHT, 681G WEIGHT). COMPLETION OF THE SBIR PHASE II AIMS WILL ENABLE INSPIRED THERAPEUTICS TO PREPARE FOR A PHASE IIB STUDY TO ACHIEVE DESIGN FREEZE OF THE COMMERCIAL CLINICAL-GRADE NEOMATE SYSTEM IN COMPLIANCE WITH GOOD MANUFACTURING PRACTICES, CONDUCT VERIFICATION AND VALIDATION TESTING, AND COMPLETE THE PRE-CLINICAL TESTING IN COMPLIANCE WITH GOOD LABORATORY PRACTICES. ENGINEERING CONTROL DOCUMENTS AND EXPERIMENTAL DATA WILL BE USED TO SUPPORT REGULATORY SUBMISSIONS FOR APPROVAL TO INITIATE A PHASE I CLINICAL TRIAL. THE LONG-TERM GOAL OF INSPIRED THERAPEUTICS IS TO BUILD UPON THIS PLATFORM TECHNOLOGY TO EVENTUALLY EXPAND THE POTENTIAL MARKETS INTO CARDIOPULMONARY BYPASS, RESPIRATORY ASSIST, EXTRACORPOREAL MEMBRANE OXYGENATION, AND BI- AND RIGHT VENTRICULAR ASSISTANCE; HOWEVER, IN THIS SBIR PHASE II APPLICATION, THE NEOMATE SYSTEM IS BEING DEVELOPED AND DESIGNED FOR LEFT VENTRICULAR ASSISTANCE AND IN THE UNDERSERVED NEONATE AND INFANT HF POPULATIONS FIRST.
Obligated Amount:
3437935.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-02-18
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
69670.00
Total Face Value Of Loan:
69670.00
Date:
2020-05-03
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
42620.00
Total Face Value Of Loan:
42620.00
Date:
2018-06-26
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DEVELOPMENT OF A PEDIATRIC CARDIAC AND RESPIRATORY ASSIST SYSTEM
Obligated Amount:
415921.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Paycheck Protection Program

Jobs Reported:
4
Initial Approval Amount:
$69,670
Date Approved:
2021-02-18
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$69,670
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$70,005.94
Servicing Lender:
Bank of America, National Association
Use of Proceeds:
Payroll: $69,670
Jobs Reported:
4
Initial Approval Amount:
$42,620
Date Approved:
2020-05-01
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$42,620
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$42,920.09
Servicing Lender:
Bank of America, National Association
Use of Proceeds:
Payroll: $42,620

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 03 Jul 2025

Sources: Florida Department of State

Privacy policy Policy
About us About us Business Directory
Contacts Contact us

© 2025 flprofile.com, Part of Big Data Integrated